Article
Comparison of two donor‐derived cell‐free DNA tests and a blood gene‐expression profile test in heart transplantation
10 Apr 2023
Abstract excerpt
BACKGROUND: Donor-derived cell-free DNA (dd-cfDNA) testing is an emerging screening modality for noninvasive detection of acute rejection (AR). This study compared the testing accuracy for AR of two commercially available dd-cfDNA and gene-expression profiling (GEP) testing in heart transplant (HTx) recipients. METHODS: This is a retrospective, observational study of HTx only patients who underwent standard and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
